Filings

7 documents · 17 matches

1. STOK Stoke Therapeutics, Inc. 10-K 2026-03-16

   Item 1A. Risk Factors.

   weaknesses in our internal controls. If material weaknesses or deficiencies in our internal controls exist and go undetected or unremediated
   2 matches in this document Show context Copy citation

2. STOK Stoke Therapeutics, Inc. 10-Q 2025-11-04

   Item 1A. Risk Factors.

   weaknesses in our internal controls. If material weaknesses or deficiencies in our internal controls exist and go undetected or unremediated
   2 matches in this document Show context Copy citation

3. STOK Stoke Therapeutics, Inc. 10-Q 2025-08-12

   Item 1A. Risk Factors.

   weaknesses in our internal controls. If material weaknesses or deficiencies in our internal controls exist and go undetected or unremediated
   2 matches in this document Show context Copy citation

4. STOK Stoke Therapeutics, Inc. 10-Q 2025-05-13

   Item 1A. Risk Factors.

   weaknesses in our internal controls. If material weaknesses or deficiencies in our internal controls exist and go undetected or unremediated
   2 matches in this document Show context Copy citation

5. STOK Stoke Therapeutics, Inc. 10-Q 2026-11-03

   Item 1A. Risk Factors.

   weaknesses in our internal controls. If material weaknesses or deficiencies in our internal controls exist and go undetected or unremediated
   3 matches in this document Show context Copy citation

6. STOK Stoke Therapeutics, Inc. 10-Q 2026-08-03

   Item 1A. Risk Factors.

   weaknesses in our internal controls. If material weaknesses or deficiencies in our internal controls exist and go undetected or unremediated
   3 matches in this document Show context Copy citation

7. STOK Stoke Therapeutics, Inc. 10-Q 2026-05-07

   Item 1A. Risk Factors.

   weaknesses in our internal controls. If material weaknesses or deficiencies in our internal controls exist and go undetected or unremediated
   3 matches in this document Show context Copy citation